- Sarepta Therapeutics (SRPT, Financial) will release its Q1 2025 financial results on May 6, 2025, after the market closes.
- The company will host a conference call at 4:30 p.m. E.T. to discuss the earnings, accessible via webcast and phone.
- A replay of the earnings call will be available on Sarepta's website for one year.
Sarepta Therapeutics, Inc. (SRPT), renowned for its work in precision genetic medicine for rare diseases, is set to release its first-quarter 2025 financial results. Investors and interested parties can expect the announcement on Tuesday, May 6, 2025, following the Nasdaq Global Market closure.
Immediately after the release, Sarepta will hold a conference call at 4:30 p.m. E.T. to discuss the financial outcomes and corporate developments. The event will be webcast live on the investor relations section of the company's website. For those preferring to join via phone, registration is required to receive dial-in details, including a personal PIN number for access.
Sarepta, leading advancements in treatments for Duchenne muscular dystrophy and limb-girdle muscular dystrophies, continues to expand its portfolio to address muscle, central nervous system, and cardiac diseases. Investors are encouraged to routinely check the company's website for crucial information and updates.
